Click for best price
Anemia Therapeutic Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Anemia Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anemia Therapeutic Drugs. This report contains market size and forecasts of Anemia Therapeutic Drugs in global, including the following market information:
Global Anemia Therapeutic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anemia Therapeutic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Supplements Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anemia Therapeutic Drugs include Pfizer, Inc., Amgen, Inc., Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Janssen Pharmaceutical, Bayer AG, AMAG Pharmaceuticals and GlaxoSmithKline plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anemia Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Therapeutic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Global Anemia Therapeutic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Global Anemia Therapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Anemia Therapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Therapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anemia Therapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anemia Therapeutic Drugs, market overview.
Chapter 2: Global Anemia Therapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of Anemia Therapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anemia Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anemia Therapeutic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anemia Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anemia Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anemia Therapeutic Drugs Overall Market Size
2.1 Global Anemia Therapeutic Drugs Market Size: 2022 VS 2030
2.2 Global Anemia Therapeutic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anemia Therapeutic Drugs Players in Global Market
3.2 Top Global Anemia Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Anemia Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anemia Therapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anemia Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anemia Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anemia Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anemia Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anemia Therapeutic Drugs Market Size Markets, 2022 & 2030
4.1.2 Supplements
4.1.3 Antibiotics
4.1.4 Immunosuppressant
4.1.5 Bone Marrow Stimulants
4.1.6 Corticosteroids
4.1.7 Gene Therapy
4.1.8 Iron Chelating Agents
4.2 By Type - Global Anemia Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anemia Therapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anemia Therapeutic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anemia Therapeutic Drugs Market Size, 2022 & 2030
5.1.2 Iron deficiency anemia
5.1.3 Thalassemia
5.1.4 Aplastic anemia
5.1.5 Hemolytic anemia
5.1.6 Sickle cell anemia
5.1.7 Pernicious anemia
5.2 By Application - Global Anemia Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anemia Therapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anemia Therapeutic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Anemia Therapeutic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anemia Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anemia Therapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anemia Therapeutic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Anemia Therapeutic Drugs Revenue, 2018-2030
6.3.2 US Anemia Therapeutic Drugs Market Size, 2018-2030
6.3.3 Canada Anemia Therapeutic Drugs Market Size, 2018-2030
6.3.4 Mexico Anemia Therapeutic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Anemia Therapeutic Drugs Revenue, 2018-2030
6.4.2 Germany Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.3 France Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.4 U.K. Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.5 Italy Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.6 Russia Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Anemia Therapeutic Drugs Market Size, 2018-2030
6.4.8 Benelux Anemia Therapeutic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Anemia Therapeutic Drugs Revenue, 2018-2030
6.5.2 China Anemia Therapeutic Drugs Market Size, 2018-2030
6.5.3 Japan Anemia Therapeutic Drugs Market Size, 2018-2030
6.5.4 South Korea Anemia Therapeutic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Anemia Therapeutic Drugs Market Size, 2018-2030
6.5.6 India Anemia Therapeutic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Anemia Therapeutic Drugs Revenue, 2018-2030
6.6.2 Brazil Anemia Therapeutic Drugs Market Size, 2018-2030
6.6.3 Argentina Anemia Therapeutic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue, 2018-2030
6.7.2 Turkey Anemia Therapeutic Drugs Market Size, 2018-2030
6.7.3 Israel Anemia Therapeutic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Anemia Therapeutic Drugs Market Size, 2018-2030
6.7.5 UAE Anemia Therapeutic Drugs Market Size, 2018-2030
7 Anemia Therapeutic Drugs Companies Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.1.4 Pfizer, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer, Inc. Key News & Latest Developments
7.2 Amgen, Inc.
7.2.1 Amgen, Inc. Company Summary
7.2.2 Amgen, Inc. Business Overview
7.2.3 Amgen, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.2.4 Amgen, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 Amgen, Inc. Key News & Latest Developments
7.3 Hoffmann-La Roche Ltd.
7.3.1 Hoffmann-La Roche Ltd. Company Summary
7.3.2 Hoffmann-La Roche Ltd. Business Overview
7.3.3 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Major Product Offerings
7.3.4 Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 Hoffmann-La Roche Ltd. Key News & Latest Developments
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Company Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck Sharp & Dohme Corp. Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Anemia Therapeutic Drugs Major Product Offerings
7.5.4 Novartis AG Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Janssen Pharmaceutical
7.6.1 Janssen Pharmaceutical Company Summary
7.6.2 Janssen Pharmaceutical Business Overview
7.6.3 Janssen Pharmaceutical Anemia Therapeutic Drugs Major Product Offerings
7.6.4 Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 Janssen Pharmaceutical Key News & Latest Developments
7.7 Bayer AG
7.7.1 Bayer AG Company Summary
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Anemia Therapeutic Drugs Major Product Offerings
7.7.4 Bayer AG Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 Bayer AG Key News & Latest Developments
7.8 AMAG Pharmaceuticals
7.8.1 AMAG Pharmaceuticals Company Summary
7.8.2 AMAG Pharmaceuticals Business Overview
7.8.3 AMAG Pharmaceuticals Anemia Therapeutic Drugs Major Product Offerings
7.8.4 AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.8.5 AMAG Pharmaceuticals Key News & Latest Developments
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Anemia Therapeutic Drugs Major Product Offerings
7.9.4 GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.9.5 GlaxoSmithKline plc Key News & Latest Developments
7.10 Akebia Therapeutics
7.10.1 Akebia Therapeutics Company Summary
7.10.2 Akebia Therapeutics Business Overview
7.10.3 Akebia Therapeutics Anemia Therapeutic Drugs Major Product Offerings
7.10.4 Akebia Therapeutics Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.10.5 Akebia Therapeutics Key News & Latest Developments
7.11 Vifor Pharma Management, Ltd.
7.11.1 Vifor Pharma Management, Ltd. Company Summary
7.11.2 Vifor Pharma Management, Ltd. Business Overview
7.11.3 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Major Product Offerings
7.11.4 Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.11.5 Vifor Pharma Management, Ltd. Key News & Latest Developments
7.12 FibroGen, Inc.
7.12.1 FibroGen, Inc. Company Summary
7.12.2 FibroGen, Inc. Business Overview
7.12.3 FibroGen, Inc. Anemia Therapeutic Drugs Major Product Offerings
7.12.4 FibroGen, Inc. Anemia Therapeutic Drugs Revenue in Global Market (2018-2023)
7.12.5 FibroGen, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anemia Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Anemia Therapeutic Drugs Market Drivers in Global Market
Table 3. Anemia Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Anemia Therapeutic Drugs in Global Market
Table 5. Top Anemia Therapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anemia Therapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anemia Therapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anemia Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Anemia Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anemia Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anemia Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Anemia Therapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anemia Therapeutic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anemia Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anemia Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer, Inc. Company Summary
Table 31. Pfizer, Inc. Anemia Therapeutic Drugs Product Offerings
Table 32. Pfizer, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer, Inc. Key News & Latest Developments
Table 34. Amgen, Inc. Company Summary
Table 35. Amgen, Inc. Anemia Therapeutic Drugs Product Offerings
Table 36. Amgen, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen, Inc. Key News & Latest Developments
Table 38. Hoffmann-La Roche Ltd. Company Summary
Table 39. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Product Offerings
Table 40. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 42. Merck Sharp & Dohme Corp. Company Summary
Table 43. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Product Offerings
Table 44. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Sharp & Dohme Corp. Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Anemia Therapeutic Drugs Product Offerings
Table 48. Novartis AG Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Janssen Pharmaceutical Company Summary
Table 51. Janssen Pharmaceutical Anemia Therapeutic Drugs Product Offerings
Table 52. Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Janssen Pharmaceutical Key News & Latest Developments
Table 54. Bayer AG Company Summary
Table 55. Bayer AG Anemia Therapeutic Drugs Product Offerings
Table 56. Bayer AG Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Bayer AG Key News & Latest Developments
Table 58. AMAG Pharmaceuticals Company Summary
Table 59. AMAG Pharmaceuticals Anemia Therapeutic Drugs Product Offerings
Table 60. AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. AMAG Pharmaceuticals Key News & Latest Developments
Table 62. GlaxoSmithKline plc Company Summary
Table 63. GlaxoSmithKline plc Anemia Therapeutic Drugs Product Offerings
Table 64. GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. GlaxoSmithKline plc Key News & Latest Developments
Table 66. Akebia Therapeutics Company Summary
Table 67. Akebia Therapeutics Anemia Therapeutic Drugs Product Offerings
Table 68. Akebia Therapeutics Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Akebia Therapeutics Key News & Latest Developments
Table 70. Vifor Pharma Management, Ltd. Company Summary
Table 71. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Product Offerings
Table 72. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Vifor Pharma Management, Ltd. Key News & Latest Developments
Table 74. FibroGen, Inc. Company Summary
Table 75. FibroGen, Inc. Anemia Therapeutic Drugs Product Offerings
Table 76. FibroGen, Inc. Anemia Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. FibroGen, Inc. Key News & Latest Developments
List of Figures
Figure 1. Anemia Therapeutic Drugs Segment by Type in 2022
Figure 2. Anemia Therapeutic Drugs Segment by Application in 2022
Figure 3. Global Anemia Therapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anemia Therapeutic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anemia Therapeutic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anemia Therapeutic Drugs Revenue in 2022
Figure 8. By Type - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Anemia Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 16. US Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 28. China Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Anemia Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Anemia Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Hoffmann-La Roche Ltd. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Sharp & Dohme Corp. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Janssen Pharmaceutical Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bayer AG Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. AMAG Pharmaceuticals Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GlaxoSmithKline plc Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Akebia Therapeutics Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Vifor Pharma Management, Ltd. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. FibroGen, Inc. Anemia Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
